Lovisa Farnebo

832 total citations
22 papers, 577 citations indexed

About

Lovisa Farnebo is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Lovisa Farnebo has authored 22 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Otorhinolaryngology and 8 papers in Surgery. Recurrent topics in Lovisa Farnebo's work include Head and Neck Cancer Studies (12 papers), Cancer-related Molecular Pathways (7 papers) and Cancer Diagnosis and Treatment (3 papers). Lovisa Farnebo is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Cancer-related Molecular Pathways (7 papers) and Cancer Diagnosis and Treatment (3 papers). Lovisa Farnebo collaborates with scholars based in Sweden, Finland and United States. Lovisa Farnebo's co-authors include Karin Roberg, Mayur Vilas Jain, Emilia Wiecheć, Man Ki Chung, Stina Garvin, Marianne Farnebo, Antti Mäkitie, Göran Laurell, Sofia Henriksson and Salah Mahmoudi and has published in prestigious journals such as PLoS ONE, Cancer and International Journal of Cancer.

In The Last Decade

Lovisa Farnebo

21 papers receiving 568 citations

Peers

Lovisa Farnebo
Lieuwe J. Melchers Netherlands
Hisazumi Ikeda Japan
Chuan-Hang Yu Taiwan
Snezana Andrejevic‐Blant Switzerland
Kenji Nakamori Japan
Tomofumi Naruse Japan
Pirjo Åström Finland
Mitsuo Goto Japan
Carolina Cavalcante Bitu Finland
Lieuwe J. Melchers Netherlands
Lovisa Farnebo
Citations per year, relative to Lovisa Farnebo Lovisa Farnebo (= 1×) peers Lieuwe J. Melchers

Countries citing papers authored by Lovisa Farnebo

Since Specialization
Citations

This map shows the geographic impact of Lovisa Farnebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lovisa Farnebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lovisa Farnebo more than expected).

Fields of papers citing papers by Lovisa Farnebo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lovisa Farnebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lovisa Farnebo. The network helps show where Lovisa Farnebo may publish in the future.

Co-authorship network of co-authors of Lovisa Farnebo

This figure shows the co-authorship network connecting the top 25 collaborators of Lovisa Farnebo. A scholar is included among the top collaborators of Lovisa Farnebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lovisa Farnebo. Lovisa Farnebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Högmo, Anders, et al.. (2024). Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden. PLoS ONE. 19(4). e0296534–e0296534. 2 indexed citations
3.
Farnebo, Lovisa, et al.. (2024). Pretreatment fat‐free mass index correlates with early death in patients with head and neck squamous cell carcinoma. Head & Neck. 46(4). 808–818. 3 indexed citations
4.
Högmo, Anders, Helena Sjödin, Maria Gebre‐Medhin, et al.. (2021). A national study of health‐related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma. Head & Neck. 43(12). 3843–3856. 6 indexed citations
5.
Saarto, Tiina, et al.. (2020). A Nordic survey of the management of palliative care in patients with head and neck cancer. European Archives of Oto-Rhino-Laryngology. 278(6). 2027–2032. 4 indexed citations
6.
Mäkitie, Antti, et al.. (2019). Early mortality after diagnosis of cancer of the head and neck – A population-based nationwide study. PLoS ONE. 14(10). e0223154–e0223154. 27 indexed citations
7.
Wiecheć, Emilia, et al.. (2019). The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer. Cancer Cell International. 19(1). 16–16. 207 indexed citations
8.
Klug, Tejs Ehlers, Sten Schytte, Lovisa Farnebo, et al.. (2019). Laryngo-tracheal resections in the Nordic countries: an option for further centralization?. European Archives of Oto-Rhino-Laryngology. 276(5). 1545–1548. 1 indexed citations
9.
Haapaniemi, Aaro, Lovisa Farnebo, Jussi Tarkkanen, et al.. (2017). WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer. Oncology Reports. 38(4). 2062–2068. 11 indexed citations
10.
Kim, Jeewon, June Ho Shin, Che‐Hong Chen, et al.. (2017). Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor. Oncotarget. 8(32). 52345–52356. 42 indexed citations
11.
Farnebo, Lovisa, Göran Laurell, & Antti Mäkitie. (2016). A Nordic survey on the management of head and neck CUP. Acta Oto-Laryngologica. 136(11). 1159–1163. 8 indexed citations
12.
Farnebo, Lovisa, Nea Malila, Antti Mäkitie, & Göran Laurell. (2016). Early death among head and neck cancer patients. Current Opinion in Otolaryngology & Head & Neck Surgery. 24(2). 115–120. 12 indexed citations
13.
Farnebo, Simon, et al.. (2016). Optimized Repopulation of Tendon Hydrogel. Hand. 12(1). 68–77. 19 indexed citations
14.
15.
16.
Farnebo, Lovisa, et al.. (2013). Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients. International Journal of Cancer. 133(8). 1994–2003. 43 indexed citations
17.
Mahmoudi, Salah, Sofia Henriksson, Lovisa Farnebo, Karin Roberg, & Marianne Farnebo. (2011). WRAP53 promotes cancer cell survival and is a potential target for cancer therapy. Cell Death and Disease. 2(1). e114–e114. 50 indexed citations
18.
Farnebo, Lovisa, Fredrik Jerhammar, Rebecca Ceder, et al.. (2011). Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines. Journal of Oral Pathology and Medicine. 40(10). 739–746. 18 indexed citations
19.
Farnebo, Lovisa, et al.. (2008). Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer. Oral Oncology. 45(1). 23–29. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lieuwe J. Melchers Breakdown of academic impact, for papers by Hisazumi Ikeda Breakdown of academic impact, for papers by Chuan-Hang Yu Breakdown of academic impact, for papers by Snezana Andrejevic‐Blant Breakdown of academic impact, for papers by Kenji Nakamori Breakdown of academic impact, for papers by Tomofumi Naruse Breakdown of academic impact, for papers by Pirjo Åström Breakdown of academic impact, for papers by Mitsuo Goto Breakdown of academic impact, for papers by Carolina Cavalcante Bitu
Rankless by CCL
2026